IL-13 Targeting Biologics for the Treatment of Atopic Dermatitis - Episode 16
Panelists discuss whether a treatment switch would be considered for a patient with 75% improvement in atopic dermatitis, weighing the benefits of continued treatment versus the potential for further improvement with a different therapy.
Video content above is prompted by the following: